CG Oncology is well-positioned to enter a de-risked NMIBC market with cretostimogene. Click here to read why CGON stock is a ...
A new editorial argues that extracellular vesicles both drive tumor adaptation and drug resistance and offer promising ...
From wider selfies to AI-assisted editing, OPPO India's Goldee Patnaik explains how smartphone cameras are adapting to the ...
Insurance companies could lose years of potential pricing gains by making core system replacement a prerequisite for ...
KEYTRUDA as Monotherapy Reduced Risk of Disease Progression or Death by 43% for Certain Patients With Advanced or Recurrent ...
Agentic AI is moving biopharma from tools that inform decisions to systems that execute them, reshaping discovery, clinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results